These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32850097)

  • 1. Transformation of CMML to AML presenting with acute kidney injury.
    DeBoer R; Garrahy I; Rettew A; Libera R
    J Community Hosp Intern Med Perspect; 2020 Aug; 10(4):353-357. PubMed ID: 32850097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Acute Kidney Injury Associated with Transformation of Chronic Myelomonocytic Leukemia into Acute Myeloid Leukemia: A Case Report.
    Lee SW; Kim MS; Kim YJ; Jung HY; Choi JY; Cho JH; Park SH; Kim CD; Kim YL; Lim JH
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report.
    Pelkey LJ; Graham DM; Zakem MH; Muza-Moons MM
    Cureus; 2022 Feb; 14(2):e22422. PubMed ID: 35228982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Synchronous Bone Marrow Chronic Myelomonocytic Leukemia (CMML) and Nodal Marginal Zone Lymphoma (NMZL).
    Soriano PK; Stone T; Baqai J; Sana S
    Am J Case Rep; 2018 Sep; 19():1135-1139. PubMed ID: 30254190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease.
    Lafargue MC; Bobot M; Rennke HG; Essig M; Carre M; Mercadal L; Farhi J; Sakhi H; Comont T; Golbin L; Isnard P; Chemouny J; Cambier N; Laribi K; Selamet U; Riella LV; Fain O; Adès L; Fenaux P; Cohen C; Mekinian A;
    Kidney Int Rep; 2023 Dec; 8(12):2733-2741. PubMed ID: 38106568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
    Singh ZN; Post GR; Kiwan E; Maddox AM
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of a Clonal T-Cell Population in a Case of Chronic Myelomonocytic Leukemia.
    Patil A; Wanve B; Kar P; Velusamy S
    Clin Med Insights Blood Disord; 2021; 14():2634853521991509. PubMed ID: 33628070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
    Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
    Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Xu Y; McKenna RW; Karandikar NJ; Pildain AJ; Kroft SH
    Am J Clin Pathol; 2005 Nov; 124(5):799-806. PubMed ID: 16203279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13, +15 double trisomy resulting in an adverse outcome.
    McGrattan P; Humphreys M; Hull D; McMullin MF
    Ulster Med J; 2007 Sep; 76(3):131-5. PubMed ID: 17853637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia.
    Picot T; Aanei CM; Flandrin Gresta P; Noyel P; Tondeur S; Tavernier Tardy E; Guyotat D; Campos Catafal L
    Front Oncol; 2018; 8():109. PubMed ID: 29707521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
    Wattel E; Guerci A; Hecquet B; Economopoulos T; Copplestone A; Mahé B; Couteaux ME; Resegotti L; Voglova V; Foussard C; Pegourié B; Michaux JL; Deconinck E; Stoppa AM; Mufti G; Oscier D; Fenaux P
    Blood; 1996 Oct; 88(7):2480-7. PubMed ID: 8839839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia.
    Helbig G; Chromik K; Woźniczka K; Kopińska AJ; Boral K; Dworaczek M; Koclęga A; Armatys A; Panz-Klapuch M; Markiewicz M
    Pathol Oncol Res; 2019 Jul; 25(3):1175-1180. PubMed ID: 30613922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia.
    Langridge A; Musgrave K; Upadhye Y
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26961554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe electrolyte derangements from lysozymuria in acute myeloid leukemia.
    Pérez-Pinzón J; Olin RL; Banerjee R
    EJHaem; 2022 Aug; 3(3):1018-1020. PubMed ID: 36051078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation.
    Peng J; Zuo Z; Fu B; Oki Y; Tang G; Goswami M; Priyanka P; Muzzafar T; Medeiros LJ; Luthra R; Wang SA
    Eur J Haematol; 2016 Jan; 96(1):65-71. PubMed ID: 25809997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.